Global Bloodstream Infection Testing Market 2020-2024

Global Bloodstream Infection Testing Market 2020-2024

The publisher has been monitoring the bloodstream infection testing market and it is poised to grow by USD 691.32 mn during 2020-2024, progressing at a CAGR of 9% during the forecast period. The reports on the bloodstream infection testing market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing hospital visits, unmet needs in developing countries, and growing government regulations increasing blood donation awareness. In addition, increasing hospital visits is anticipated to boost the growth of the market as well.

The bloodstream infection testing market analysis includes technology segment and geographical landscapes.

The bloodstream infection testing market is segmented as below:

By Technology

• Conventional testing
• Non-conventional testing

By Geographical Landscapes

• North America
• Europe
• Asia
• ROW

This study identifies the increased adoption of automation in healthcare as one of the prime reasons driving the bloodstream infection testing market growth during the next few years. Also, increasing demand for infection control committees in hospitals and the increasing number of blood donors will lead to sizable demand in the market.

The bloodstream infection testing market report covers the following areas:

• Bloodstream infection testing market sizing
• Bloodstream infection testing market forecast
• Bloodstream infection testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bloodstream infection testing market vendors that include Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the bloodstream infection testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.